Tag Archives: Nathan Vardi

FrogHeart casts an eye back to 2021 then looks forward to 2022 and contronyms

Casting an eye back isn’t one of my strong points. Thankfully I can’t be forced into making a top 10 list of some kind. Should someone be deeply disappointed (tongue in cheek) that I failed to mention one of the big 2021 stories featured here, please leave a note in the Comments for this blog and I’ll do my best to add it.

Note: I very rarely feature space exploration unless there’s a nanotechnology or other emerging technology angle to it. There are a lot of people who do a much better job of covering space exploration than I can. (If you’re interested in an overview from a Canadian on the international race to space, you can start with this December 29, 2021 posting “Looking back at a booming year in space” by Bob McDonald of CBC’s [Canadian Broadcasting Corporation] Quirks & Quarks science radio programme.)

Now, onto FrogHeart’s latest year.

2021

One of the standout stories in 2020/21 here and many, many places was the rise of the biotechnology community in British Columbia and elsewhere in Canada. Lipid nanoparticles used in COVID-19 vaccines became far better known than they ever had before and AbCellera took the business world by storm as its founder became a COVID billionaire.

Here is a sampling of the BC biotechnology/COVID-19 stories featured here,

  • “Avo Media, Science Telephone, and a Canadian COVID-19 billionaire scientist” December 30, 2020 posting
  • “Why is Precision Nanosystems Inc. in the local (Vancouver, Canada) newspaper?” January 22, 2021 posting Note: The company is best known for its work on lipid nanoparticles
  • “mRNA, COVID-19 vaccines, treating genetic diseases before birth, and the scientist who started it all” March 5, 2021 posting Note: This posting also notes a Canadian connection in relation mRNA in the subsection titled “Entrepreneurs rush in”
  • “Getting erased from the mRNA/COVID-19 story” August 20, 2021 posting Note: This features a fascinating story from Nathan Vardi (for Forbes) of professional jealousies, competitiveness, and a failure to recognize opportunity when she comes visiting.
  • “Who’s running the life science companies’ public relations campaign in British Columbia (Vancouver, Canada)?” August 23, 2021 posting Note: This explores the biotech companies, the network, and provincial and federal funding, as well as, municipal (City of Vancouver) support and more.

Sadly, I did not have time to feature this September 14, 2021 article (The tangled history of mRNA vaccines; Hundreds of scientists had worked on mRNA vaccines for decades before the coronavirus pandemic brought a breakthrough.) by Elie Dolgin for Nature magazine.

Dolgin starts the story in 1987 and covers many players that were new to me although I did recognize some of the more recent and Canadian players such as Pieter Cullis and Ian MacLachlan. *ETA January 3 ,2021: Cullis and MacLachlan are both mentioned in my ‘Getting erased ..” August 20, 2021 posting.* Fun fact: Pieter Cullis was just named an Officer to the Order of Canada (from the Governor General’s December 29, 2021 news release),

Pieter Cullis, O.C.
Vancouver, British Columbia

For his contributions to the advancement of biomedical research and drug development, and for his mentorship of the next generation of scientists and entrepreneurs.

Back to this roundup, I got interested in greener lithium mining, given its importance for batteries in electric vehicles and elsewhere,

2021 seems to have been the year when the science community started podcasting in a big way. Either the podcast was started this year or I stumbled across it this year (meaning it’s likely a podcast that is getting publicized because they had a good first year and they want more listeners for their second year),

  • “New podcast—Mission: Interplanetary and Event Rap: a one-stop custom rap shop Kickstarter” April 30, 2021 posting
  • “Superstar engineers and fantastic fiction writers podcast series” June 28, 2021 posting
  • “Periodically Political: a Canadian podcast from Elect STEM” August 16, 2021 posting
  • “Unlocking Science: a new podcast series launches on November 16, 2021” November 16, 2021 posting
  • “Lost Women of Science” December 2, 2021 posting
  • “Nerdin’ About and Science Diction: a couple of science podcasts” Note: Not posted but maybe one day. Meanwhile, here they are:
    • Nerdin’ About describes itself as, “… a podcast where passionate nerds tell us about their research, their interests, and what they’ve been Nerdin’ About lately. A spin-off of Nerd Nite Vancouver, a community lecture series held in a bar, Nerdin’ About is here to explore these questions with you. Hosted by rat researcher Kaylee Byers (she/her) and astronomy educator Michael Unger (he/him). Elise Lane (she/her) is our Mixing Engineer. Music by Jay Arner. Artwork by Armin Mortazavi.”
    • Science Diction is a podcast offshoot of Science Friday (SciFri), a US National Public Radio (NPR) programme. “… Hosted by SciFri producer and self-proclaimed word nerd Johanna Mayer, each episode of Science Diction digs into the origin of a single word or phrase, and, with the help of historians, authors, etymologists, and scientists, reveals a surprising science connection. Did you know the origin of the word meme has more to do with evolutionary biology than lolcats? Or that the element cobalt takes its name from a very cheeky goblin from German folklore? …”
  • Podcast episode from the Imperial College London features women’s hearts, psychedelic worldviews, and nanotechnology for children” Note: Not posted but maybe one day.
  • Alberta-based podcast explores AI (Artificial Intelligence)” Note 1: You’ll find season one and two on the page I’ve linked to; just keep scrolling. Note 2: Not posted but maybe one day.
  • Own the Science Podcast/À vous la science balado” Note: Not posted but maybe one day.

Integrating the body with machines is an ongoing interest of mine, these particular 2021 postings stood out but there are other postings (click on the Human Enhancement category or search the tag ‘machine/flesh’),

I wrote a few major (long) pieces this year,

  • “Interior Infinite: carnival & chaos, a June 26 – September 5, 2021 show at Polygon Art Gallery (North Vancouver, Canada)” July 26, 2021 posting Note: While this isn’t an art/sci posting it does touch on a topic near and dear to my heart, writers. In particular, the literary theorist, Mikhail Mikhailovich Bakhtin.
  • “The metaverse or not” October 22, 2021 posting Note: What can I say? The marketing hype got to me.
  • “True love with AI (artificial intelligence): The Nature of Things explores emotional and creative AI (long read)” December 3, 2021 posting

2022 and contronyms

I don’t make psychic predictions. As far as I’m concerned, 2022 will be a continuation of 2021, albeit with a few surprises.

My focus on nanotechnology and emerging technologies will remain. I expect artificial intelligence, CRISPR and gene editing (in general), quantum computing (technical work and commercialization), and neuromorphic computing will continue to make news. As for anything else, well, it wouldn’t be a surprise if you knew it was coming.

With regard to this blog, I keep thinking about cutting back so I can focus on other projects. Whether I finally follow through this year is a mystery to me.

Because words and writing are important to me, I’d like to end the year with this, which I found in early December 2021. From “25 Words That Are Their Own Opposites” on getpocket.com by Judith Herman originally written for “Mental Floss and … published June 15, 2018,”

Here’s an ambiguous sentence for you: “Because of the agency’s oversight, the corporation’s behavior was sanctioned.” Does that mean, “Because the agency oversaw the company’s behavior, they imposed a penalty for some transgression,” or does it mean, “Because the agency was inattentive, they overlooked the misbehavior and gave it their approval by default”? We’ve stumbled into the looking-glass world of contronyms—words that are their own antonyms.

1. Sanction (via French, from Latin sanctio(n-), from sancire ‘ratify,’) can mean “give official permission or approval for (an action)” or conversely, “impose a penalty on.”

2. Oversight is the noun form of two verbs with contrary meanings, “oversee” and “overlook.” Oversee, from Old English ofersēon (“look at from above”) means “supervise” (medieval Latin for the same thing: super-, “over” plus videre, “to see.”) Overlook usually means the opposite: “to fail to see or observe; to pass over without noticing; to disregard, ignore.”

3. Left can mean either remaining or departed. If the gentlemen have withdrawn to the drawing room for after-dinner cigars, who’s left? (The gentlemen have left and the ladies are left.)

4. Dust, along with the next two words, is a noun turned into a verb meaning either to add or to remove the thing in question. Only the context will tell you which it is. When you dust are you applying dust or removing it? It depends whether you’re dusting the crops or the furniture.

The contronym (also spelled “contranym”) goes by many names, including auto-antonym, antagonym, enantiodrome, self-antonym, antilogy and Janus word (from the Roman god of beginnings and endings, often depicted with two faces looking in opposite directions). …

Herman made liberal use, which she acknowledged, of the Mark Nichol article/list, “75 Contronyms (Words with Contradictory Meanings)” on Daily Writing Tips (Note: Based on the ‘comments’, Nichol’s list appears to be have been posted sometime in 2011),

3. Bill: A payment, or an invoice for payment

4. Bolt: To secure, or to flee

46. Quantum: Significantly large, or a minuscule part

47. Quiddity: Essence, or a trifling point of contention

68. Trim: To decorate, or to remove excess from

69. Trip: A journey, or a stumble

Happy 2022!

Getting erased from the mRNA/COVID-19 story

Nathan Vardi’s August 17, 2021 article for Forbes magazine about Ian MacLachlan and the delivery system for mRNA vaccines tells a type of story I’ve more often seen in history books. It is reminiscent of the Thomas Edison and Nikola Tesla story of electricity. One gets all the glory while the other is largely forgotten.

I’m especially interested as much of this concerns players in the local (Vancouver, British Columbia, Canada) biotechnology scene. Vardi’s August 17, 2021 article sets the scene,

“The whole mRNA platform is not how to build an mRNA molecule; that’s the easy thing,” Bourla [Pfizer CEO Albert Bourla] says. “It is how to make sure the mRNA molecule will go into your cells and give the instructions.” 

Yet the story of how Moderna, BioNTech and Pfizer managed to create that vital delivery system has never been told. It’s a complicated saga involving 15 years of legal battles and accusations of betrayal and deceit. [emphases mine] What is clear is that when humanity needed a way to deliver mRNA to human cells to arrest the pandemic, there was only one reliable method available—and it wasn’t one originated in-house by Pfizer, Moderna, BioNTech or any of the other major vaccine companies. 

A months-long investigation by Forbes reveals that the scientist most responsible for this critical delivery method is a little-known 57-year-old Canadian biochemist named Ian MacLachlan. As chief scientific officer of two small companies, Protiva Biotherapeutics and Tekmira Pharmaceuticals, MacLachlan led the team that developed this crucial technology. Today, though, few people—and none of the big pharmaceutical companies—openly acknowledge his groundbreaking work, and MacLachlan earns nothing from the technology he pioneered. 

I have three stories (on this blog) mentioning Tekmira (all from 2014 or 2015) and none mentioning Protiva nor, for that matter, Ian MacLachlan.

Back to Vardi’s August 17, 2021 article,

Moderna Therapeutics vigorously disputes the idea that its mRNA vaccine uses MacLachlan’s delivery system, and BioNTech, the vaccine maker partnered with Pfizer, talks about it carefully. Legal proceedings are pending, and big money is at stake. 

Moderna, BioNTech and Pfizer are on their way to selling $45 billion worth of vaccines in 2021. They don’t pay a dime to MacLachlan. Other coronavirus vaccine makers, such as Gritstone Oncology, have recently licensed MacLachlan’s Protiva-Tekmira delivery technology for between 5% and 15% of product sales. MacLachlan no longer has a financial stake in the technology, but a similar royalty on the Moderna and Pfizer-BioNTech vaccines could yield as much as $6.75 billion in 2021 alone. …

Vardi provides evidence (Note: A link has been removed from the August 17, 2021 article excerpt,

Despite their denials, scientific papers and regulatory documents filed with the FDA [US Food and Drug Administration] show that both Moderna and Pfizer-BioNTech’s vaccines use a delivery system strikingly similar to what MacLachlan and his team created—a carefully formulated four-lipid component that encapsulates mRNA in a dense particle through a mixing process involving ethanol and a T-connector apparatus. 

For years, Moderna claimed it was using its own proprietary delivery system, but when it came time for the company to test its Covid-19 vaccine in mice, it used the same four kinds of lipids as MacLachlan’s technology, in identical ratios. 

According to Vardi’s LinkedIn profile: “I am a senior editor at Forbes, where I am responsible for the coverage of hedge funds, private equity, and other big investors. I lead investigative reporting efforts and have written 20 cover stories for Forbes Magazine,” he does not appear to have any medical or bioscience expertise (Bachelor of Journalism from Carleton University [Canada] and Masters of International Affairs from Columbia University [US].) Presumably someone he consulted or someone on his team provided the skills necessary for analyzing the scientific papers and documents.

You may recognize this scientist (from the August 17, 2021 article),

Not everyone ignores MacLachlan. “A lot of credit goes to Ian MacLachlan for the LNP [lipid nanoparticle],” says Katalin Karikó, [emphasis mine] the scientist who laid the groundwork for mRNA therapies before joining BioNTech in 2013. But Karikó, now a frontrunner for a Nobel Prize, is angry that MacLachlan didn’t do more to help her use his delivery system to build her own mRNA company years ago. “[MacLachlan] might be a great scientist, but he lacked vision,” she says.

I have more about Karikó and her role in the mRNA vaccine story here in a March 5, 2021 posting.

As for MacLachlan’s start (from the August 17, 2021 article),

… With a Ph.D. in biochemistry, MacLachlan joined Inex in 1996, his first job after completing a postdoctoral fellowship in a gene lab at the University of Michigan. 

Inex was cofounded by its chief scientific officer, Pieter Cullis, now 75, a long-haired physicist who taught at the University of British Columbia. From his perch there Cullis started several biotechs, cultivating an elite community of scientists that made Vancouver a hotbed of lipid chemistry. 

As companies rise and fall with intellectual property being assigned to one company or other, legal brawls ensue. This was the time that Karikó came knocking on the door, from the August 17, 2021 article,

It was in the midst of all this furious legal fighting that Hungarian biochemist Katalin Karikó first showed up at MacLachlan’s door. Karikó was early to grasp that MacLachlan’s delivery system held the key to unlocking the potential of mRNA therapies. As early as 2006, she began sending letters to MacLachlan urging him to encase her groundbreaking chemically altered mRNA in his four-lipid delivery system. Embroiled in litigation, MacLachlan passed on her offer. 

Karikó didn’t give up easily. In 2013, she flew to meet with Tekmira’s executives, offering to relocate to Vancouver and work directly under MacLachlan. Tekmira passed. “Moderna, BioNTech and CureVac all wanted me to work for them, but my number one choice, Tekmira, didn’t,” says Karikó, who took a job at BioNTech in 2013. 

By this time, Moderna CEO Stéphane Bancel [emphasis mine] was also trying to solve the delivery puzzle. Bancel held discussions with Tekmira about collaborating, but talks stalled. At one point, Tekmira indicated it wanted at least $100 million up front, plus royalties, to strike a deal.

Instead, Moderna partnered with Madden [Thomas Madden], who was still working with Cullis at their drug delivery company, Acuitas Therapeutics.  …

I have been wondering why Acuitas Therapeutics hasn’t been getting all that much attention in the hyperbolic discussions about British Columbia’s (or Vancouver’s) thriving biotechnology scene. (I’ll have more about the ‘scene’ in a later posting.) Perhaps all this legal wrangling is not considered helpful when bragging. (I do have a November 12, 2020 post, which features Acuitas, an interview with its president and chief executive office Dr. Thomas Madden, and an explanation of their technology.)

As for Moderna, I have a special interest as the company has announced plans to open a production facility here in Canada and one of Moderna’s founders is Canadian, Derek Rossi. (He too is mentioned in the March 5, 2021 posting, scroll down to the ‘Entrepreneurs rush in’ subhead; he is not an altogether happy camper.)

Rossi has opinions on how we should be doing things here as noted in a June 17, 2021 article by Barbara Shecter for the Financial Post (Moderna founder says Canada needs to build a biotech hub to avoid ‘getting caught with its pants down next time’). Thank you, Mr. Rossi. (I’m more familiar with clusters than hubs [hubs were a popular topic of conversation about 20 years ago but in Canada we seem more interested in clusters; see John Newbigin’s “Hubs, clusters and regions” on britishcouncil.org for a description of the differences].)

As for Moderna’s response to all of the legal wrangling over mRNA delivery systems, from Vardi’s August 17, 2021 article,

Moderna pursued a different strategy. It filed lawsuits with the U.S. Patent and Trademark Office seeking to nullify a series of patents related to MacLachlan’s delivery system, now controlled by Genevant. But in July 2020, as Moderna was pushing its vaccine through clinical trials, an adjudicative body largely upheld the most important patent claims. (Moderna is appealing.)

I highly recommend reading Vardi’s August 17, 2021 article as I have not done justice to all of the ‘ins and outs’ of the story.

You can see how thoroughly MacLachlan has been erased form the lipid nanoparticle delivery system/COVID-19 vaccine story in this May 24 ,2021 posting (Lipid nanoparticles: The underrated invention behind the vaccine revolution) by Nada Salem at the Science Borealis blog. It is largely a description of the technology and in the last two paragraphs a history of its development with no mention of MacLachlan or any of his companies.

One last thought, I wonder how Vardi found out about MacLachlan. Could someone have brought the story to his attention and who might that have been?